Showing results (241-250 of 265) with videos related to
Sort By:
Pageof 27
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025Ruth Link-Gelles, Sean Chickery, Alexander Webber, et al.MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.MMWR. Morbidity and Mortality Weekly Report|October 5, 2023
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023Diya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.JAMA Network Open|April 4, 2024
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsDiya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.The Journal of Infectious Diseases|April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsJennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.MMWR. Morbidity and Mortality Weekly Report|August 26, 2021
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021Mark W Tenforde, Wesley H Self, Eric A Naioti, et al.MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021Mark W Tenforde, Manish M Patel, Manjusha Gaglani, et al.Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United StatesKatherine Adams, Jillian P Rhoads, Diya Surie, et al.Pageof 27